Casi Pharma announces CNCT19 (CD19 CAR-T) granted ODD by The U.S. FDA
18 Jan 2022 //
PRNEWSWIRE
Juventas Cell Therapy closes a $63M funding round
25 Oct 2021 //
FIERCEBIOTECH
Juventas Cell Therapy Closes Series C Financing
20 Jul 2021 //
DIGITALJOURNAL